Can we consider discontinuing primary prophylaxis in adults with severe haemophilia?
Fischer
K
K
Van Creveldkliniek, Department of Haematology, University Medical Center Utrecht, Utrecht, The Netherlands. k.fischer@umcutrecht.nl
D000328:Adult; D001779:Blood Coagulation Factors / Q000627:therapeutic use*; D006395:Hemarthrosis / Q000517:prevention & control; D006467:Hemophilia A / Q000188:drug therapy*; D006470:Hemorrhage / Q000517:prevention & control*; D006801:Humans; D010641:Phenotype; D028761:Withholding Treatment
D001779:Blood Coagulation Factors